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Abstract
Introduction: Turner’s syndrome (TS) is caused by a partial or total deletion of an X chromo-
some, occurring in 1:2,000 to 1:5,000 live born females. Hearing loss is one of its major clinical 
manifestations. However, there are few studies investigating this problem. 
Objectives: To review the current knowledge regarding the epidemiology, etiology, clinical 
manifestations and diagnosis of hearing impairment in patients with TS. 
Methods: A bibliographic search was performed in the Medline and Lilacs databanks (1980-2012) 
to identify the main papers associating Turner’s syndrome, hearing impairment and its clinical 
outcomes. 
Conclusions: Recurrent otitis media, dysfunction of the Eustachian tube, conductive hearing 
loss during infancy and sensorineural hearing loss in adolescence are the audiologic disorders 
more common in ST. The karyotype appears to be important in the hearing loss, with stud-
ies demonstrating an increased prevalence in patients with monosomy 45,X or isochromosome 
46,i(Xq). Morphologic studies of the cochlea are necessary to help out in the clarifying the 
etiology of the sensorineural hearing loss.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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Perda auditiva em pacientes com síndrome de Turner: revisão da literatura
Resumo
Introdução: A síndrome de Turner (ST) é causada por uma deleção total ou parcial de um cro-
mossomo X, ocorrendo em 1:2.000 até 1:5.000 meninas nascidas vivas. A perda auditiva é uma 
de suas principais manifestações clinicas. Entretanto, existem poucos estudos na literatura 
descrevendo essa associação. 
Objetivo: Rever o conhecimento atual sobre a epidemiologia, etiologia, manifestações clínicas 
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Introduction
Turner’s syndrome (TS) is a rare disease with known geno-
typic and phenotypic variability1 that affects females in a 
ratio of 1:2,000 to 1:5,000 live births.2-6 This syndrome is 
caused by a partial or total deletion of sexual chromosome. 
About half of the subjects have a karyotype 45,X; 20%-30% 
have mosaicism, and the remainder have structural abnor-
malities.7-9
The complete or partial loss of the X chromosome causes 
the phenotypic manifestations of Turner’s syndrome,8 includ-
ing: short stature, webbing of the neck, low posterior hair-
line, cubitus valgus, cardiac malformations (e.g., coarctation 
of the aorta, aortic root dilatation), kidney malformations 
(e.g., horse shoe kidney), and ovarian dysgenesis2,4,10,11 
(Figs. 1 and 2). 
The association of otitis media, hearing loss and TS 
was reported in the early 60’s, being confirmed by later 
studies.12,WLVUHFRJQL]HGWKDWLQGLYLGXDOVZLWK76KDYH
a higher incidence of middle ear disease and hearing 
problems than non-TS subjects.13 The associated hear-
ing impairment has been described as both conductive 
and sensorineural, indicating both middle and inner ear 
involvement.13
Recently some studies have described the role of the 
SHOX (short stature homeobox containing-gene) gene 
in the pathophysiology of the short stature and hearing 
problems in TS.14 The short stature is mainly due to SHOX 
KDSORLQVXIILFLHQF\DQGLVFKDUDFWHUL]HGE\DVKRUWIDOORI
approximately 20 cm from the predicted adult height.15
The SHOX gene belongs to a family of homeobox 
genes, transcriptional regulators, and key controllers 
of the development process. It is expressed within the 
pharynx involving the first and second arches of the 
embryo from six weeks of pregnancy on. These arches 
develop into the maxilla, mandible, and ossicles of the 
middle ear; muscles involved in opening the Eustachian 
tube, dampening sounds, chewing, modulating tension 
of the soft palate, and changing facial expressions; 
and most of the tongue and outer ear.14 Therefore, in 
patients with TS, the haploinsufficiency of SHOX ex-
pression is a possible explanation for features such as 
a high palate, prominent ears, chronic otitis media, 
obstructive sleep apnea, increased sensitivity to noise, 
and problems such as learning how to suck, blow, eat, 
and articulate.7,14
Chronic, severe otitis media is common in TS and is 
thought to be due to obstructed drainage either from 
lymphatic insufficiency or skeletal dysplasia. The oti-
tis may be associated with a conductive hearing loss in 
childhood, which usually resolves as otitis decreases in 
the young adult stage. However, sensorioneural hearing 
loss affects many young adults with TS and worsens with 
age. Thus, audiological screening and care are import-
ant in both girls and women with TS.15
Among the many chronic health problems faced by 
individuals with TS, ear disease and hearing loss are 
two of the most significant and troublesome. Although a 
number of cross-sectional, mainly retrospective, studies 
have reported an increased prevalence of otitis media 
and hearing loss in school-aged girls and women with TS, 
a no large-scale and prospective study has investigated 
the prevalence and natural history of ear disease and 
hearing loss in infants and toddlers.16
In this article, we aimed to review the current 
knowledge regarding the epidemiology, etiology, clinical 
manifestations and diagnosis of hearing impairment in 
patients with TS.
Conclusões: Otite média de repetição, disfunção das trompas de Eustáquio, perdas auditivas 
FRQGXWLYDVGXUDQWHDLQIkQFLDHSHUGDVDXGLWLYDVVHQVRULRQHXUDLVDSDUWLUGDDGROHVFrQFLDVmR
os distúrbios audiológicos mais comuns na ST. O cariótipo parece ter relação com a perda au-
GLWLYDFRPHVWXGRVPRVWUDQGRDXPHQWRGDSUHYDOrQFLDGHSHUGDDXGLWLYDHPSDFLHQWHVFRP
monossomia 45,X e isocromossomos 46,i(Xq). Estudos morfológicos da cóclea são necessários 
para ajudar a esclarecer a etiologia da perda auditiva sensorioneural.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
Figure 1 Frontal view of a patient with Turner’s syndrome.
Figure 2 Lateral view of a patient with Turner’s syndrome.
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Methods
The Medline, Lilacs, ProQuest, Cochrane and Embase data-
bases were searched for studies published from 1980-2012. 
The following keywords, were used combined in different 
ways: Turner’s syndrome; hearing loss; auditory dysfunc-
tion; hearing impairment, otitis media, and audiological 
evaluation. The literature review included consensuses, 
editorials, original articles and review articles written in 
English or Portuguese. Studies were initially selected based 
on their titles and abstracts. The desired outcomes were 
hearing loss, auditory dysfunction and its clinical manifesta-
tions. A review of the bibliographic references of all articles 
found was performed with the purpose of expanding the 
search. Sixty articles met the inclusion criteria and, there-
fore, were searched and included in the present review of 
literature.
Hearing loss in Turner’s syndrome
Otitis media is extremely common in girls with TS and about 
15% of adults with TS experience hearing loss.17 Hearing loss 
in Turner’s syndrome may be conductive, sensorioneural, or 
mixed. At least 25% of adults have hearing loss that requires 
hearing aids. Recurrent otitis media is common, presumably 
as a result of abnormal Eustachian tube structure and func-
tion. Recurrent infections lead to scarring of the tympanic 
membrane and conductive hearing loss, which may occur 
even in early childhood. As affected women grow older they 
become susceptible to a progressive sensorioneural hearing 
loss that may be related to premature ageing. Because some 
of these losses may be subtle but functionally impairment, 
routine hearing evaluation should be carried out through 
adulthood, particularly in patients with poor school perfor-
mance.18
7DEOHVXPPDUL]HVWKHPDLQFKDUDFWHULVWLFVRIFRQGXF-
tive and sensorineural hearing loss in Turner’s syndrome.
Conductive hearing loss
Epidemiology
Estimatives of the incidence of conductive hearing loss 
(CHL) in TS are reported to be as high as 80%, with dys-
function of the Eustachian tube and otitis media affecting 
up to 88% of the patients.19,20 The high prevalence of otitis 
PHGLDLQ76LVDQLPSRUWDQWIDFWRUWKDWSRVVLEO\LQÁXHQFHV
the individual neuromotor phenotype, and otherwise may 
cause balance disorders healthy children.21 Besides that, in 
the context envolving CHL in TS, deafness is common and 
under-reported.22
The CHL is more prevalent in children and adolescents 
than in adults, and the frequency of ear infections de-
creases with aging and growth of facial structures.23 The 
increased awareness of hearing problems in TS and the cor-
respondent better otologic care may have contributed to a 
recent decrease in the CHL as a complication of middle ear 
diseases.24
Table 1 Main characteristics of Conductive (CHL) and Senso-
rioneural (SNHL) hearing loss in Turner syndrome.
Characteristics CHL SNHL
Age
More common 
in children
More common in 
adult and elderly
Disorders of middle ear Yes No
Disorders of inner ear No Yes
Craniofacial 
malformation
Yes No
Monosomy 45, X Yes Yes
Recurrent otitis media Yes No
Decreased serum levels 
of IGF-1
Yes Yes
Progressive course No Yes
Decreased serum levels 
of estrogens
No Yes
Decreased bone mineral 
density
Yes No
Inheritance of paternal X No Yes
Deletion of the short arm 
‘p’ of the X chromosome
Yes Yes
Deletion of the long arm 
‘q’ of the X chromosome
No Yes
Disturbance of cranial 
nerve VIII
No Yes
Prevalence 10% to 47% 50% to 90%
Diagnosis
Audiological 
evaluation
Audiological 
evaluation
Treatment Hearing aid
Hearing aid or 
cochlear implant
CHL, Conductive Hearing Loss; SNHL, Sensorineural Hearing 
Loss; IGF-, Insulin-like Growth Factor 1.
Etiology
The main reason for CHL in TS is recurrent persistent otitis 
media with effusion, chronic middle ear infection, ossicular 
degeneration following chronic otitis media and cholestea-
toma in the middle ear.25 These conditions result from mal-
function of the Eustachian tube and anatomic malformation 
of the skull base, that causes poor drainage and inadequate 
ventilation of the middle ear and facilitates nasopharyngeal 
organisms to reach the middle ear.10,25,26 Palatal dysfunc-
tion in these patients may be exacerbated by the removal 
of adenoids.5
Abnormalities of the external ear: low-set and/or 
cupped auricles, abnormal slopping of the helix down-
ward, forward narrowing of the outer meatus and up-
ward-slanting external auditory canals, are the most 
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common ear anomalies seen in TS.6,27 Besides that, Turn-
er’s syndrome is also associated with stapes anomaly and 
TS patients are thought to have an increased incidence 
of cleft palate.28 Although computed tomography scan-
ning of the middle ear has not revealed structural anoma-
lies,29 Bergamaschi et al.30IRXQGDVLJQLÀFDQWDVVRFLDWLRQ
between CHL and cranio-facial abnormalities, especially 
pterygium colli, micrognatia, high arched palate and low-
set ears. 
The middle ear disorders in TS are, therefore, sec-
ondary to abnormalities in the ear anatomy such as: 
(1) lymphatic hypoplasia causing persistent lymphat-
ic effusion in the middle ear impairing aeration and 
drainage; (2) abnormal tympanic ostium of the tube; 
(3) hypotonia of the tensor veli palatine muscle; and 
(4) brachycephaly an high-arched palate causing abnor-
PDOO\KRUL]RQWDO(XVWDFKLDQWXEHVDQGSRVVLEOHSDODWDO
dysfunction.20,31,32
Apart from inflammation of the middle ear, recent 
research showed that hearing loss, middle ear infec-
tions, and malformations of the external ear in TS are 
related to the degree of deletion of the p-arm (short 
arm of the X chromosome) indicating that the hearing 
loss is also likely associated to the karyotype.26 Some 
studies have suggested that monosomy 45,X and isochro-
mosome 46,i(Xq) are significantly associated with CHL 
in TS patients10 indicating that a loss of a gene in the 
short arm (p) of the chromosome X, like SHOX could be 
involved.33 Other authors, however, did not find associ-
ation between CHL and karyotype.30
The otological problems leading to CHL have also being 
associated with decrease in serum levels of insulin-like 
growth factor 1 (IGF-1). Barrenäs et al.34 reported that 
the low levels of IGF-1 correlated with a high occurrence 
of otitis media. Growth hormone supplementation was 
effective in ameliorating the otitis media suggesting that 
this problem could be caused by hypoplasy of the skull 
base and mastoid cavity.35 In addition, Davenport et al.16 
reported evidences that GH treatment does not increase 
the occurrence of ear problems in young girls with TS. 
Unfortunately, accurate studies on the effect of growth 
hormone use and hearing outcomes will be almost impos-
sible, since the majority of TS patients receive growth 
hormone supplementation.19
The etiology of the recurrent otitis media does not 
appear to be related to an immunological dysfunction.34
Clinical manifestations
Although approximately 30% of 10-years-old girls or younger 
had a conductive hearing loss,36 as the middle ear infections 
decrease with age, by late adolescence this complication is 
almost absent.37 Unlike sensorineural hearing loss, the CHL 
is not progressive with age.
,QDGGLWLRQWRWKHÀQGLQJVDERYHWKHLQFLGHQFHRIFKR-
lesteatoma is higher in TS than in general population, being 
bilateral in 90% of the cases and diagnosed at the mean age 
of 15.5 years.30 Women with TS who have low bone mineral 
density (BMD) and hearing impairment, particularly of the 
conductive type, are at an increased risk of bone fractures. 
Improvement of both BMD and hearing ability may help out 
in reducing fracture risk.38
Sensorineural hearing loss
Epidemiology
Ear disease in adult patients with TS is complicated by pro-
gressive sensorineural hearing loss (SNHL).1 SNHL usually 
begins in the late childhood-early adulthood in a gradually 
progressive manner10 and it is a major feature of Turner’s 
syndrome.22,QWKHVSHFLDOL]HGOLWHUDWXUHLQFLGHQFHVRIVHQ-
sorineural hearing loss for populations of patients up to 42 
years-old range from 11% to 67%.1 Nonetheless, in one stu-
dy, 90% of 44% adults with Turner’s syndrome had sensori-
QHXUDOKHDULQJORVV7KHORVVZDVFOLQLFDOO\VLJQLÀFDQWLQWZR
thirds of the individuals, and 27% of them required hearing 
aids5. In addition, Kavoussi et al.39 reported that sensori-
neural hearing loss is extremely common in women with TS, 
affecting up to 90% of individuals, and consequently causing 
GLIÀFXOWLHVDWVFKRROZRUNDQGLQVRFLDOLQWHUDFWLRQVRIDGR-
lescents.
The incidence of SNHL varies from 16%-60% for mid-fre-
quencies losses to 11%-40% for high-frequencies losses.20 
Although the classical audiometric pattern of SNHL in TS 
is mid-frequency hearing loss, some authors have reported 
higher incidence of high-frequency pattern.26 The discrep-
ancy among this data may be related to the difference in 
GHÀQLWLRQLQWKHGLSSDWWHUQ:KHUHDVLQYHVWLJDWRUVVXFKDV
+XOWFUDQW]HWDO40GHÀQHLWDVDQHOHYDWLRQRIWKHWKUHVK-
ROGH[FHHGLQJG%LQWKHPLGGOHIUHTXHQFLHVN+]
others, such as Morimoto et al.,26GHÀQHLWDVH[FHHGLQJ
G%2QWKHRWKHUKDQGRWKHULQYHVWLJDWRUVGHÀQHLWDVH[-
ceeding 20 dB.25,26 Other possible explanation for the vari-
able results is that the progressive high-frequency hearing 
loss hides the dip in the middle frequencies.26 Finally, some 
studies may have included children so young in whom the 
dip may have not yet developed.25
Etiology
The causes of high-frequency hearing loss in TS remain 
controversial. The most frequently studied mechanisms are: 
age, karyotype (e.g., monosomy vs dissomy, paternal origin 
RIWKH;FKURPRVRPH;SVXSSUHVVLRQHVWURJHQGHÀFLHQF\
DQGRUJURZWKKRUPRQHDQG,*)GHÀFLHQF\DQGFRFKOHDU
abnormalities.10,26,37
The SNHL has been attributed to a X-linked dosage 
effect, because the hearing decline is more common in 
TS with a complete monosomy for the short arm (p-arm), 
such as 45,X and 46,Xi(Xq) karyotypes, than in individuals 
with smaller X deletions.41,42 It is possible that genes, 
such as SHOX, could induce a delayed cell cycle and few-
er sensory cells in the cochlea at birth resulting in cochle-
ar dysfunction.26
The majority of patients with TS inherit their intact X 
chromosome (Xintact) from their mothers.43 The genomic 
imprinting, a phenomenon by which there is a differential 
expression of some genes depending on their chromosome 
origin have been demonstrated in TS.44 Following this 
reasoning, Hamelin et al.41 reported that, after pure tone 
audiometry testing, the prevalence of SNHL was great-
er in TS patients inheriting the paternal X chromosome 
(Xpaternal) than Xmaternal subjects, providing evidence of 
a X-linked effect on the occurrence of SNHL. In addition, 
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TS subjects with a 46,X,i(Xq) karyotype have the highest 
prevalence of SNHL probably because these individuals 
inherit more often the Xpaternal chromosome.41,44 These 
ÀQGLQJV VXJJHVW WKDW JHQHV H[SUHVVHG LQ WKH ;maternal 
chromosome may protect against SNHL.41
Abnormal BAEP (Brainstem Auditory Evoked Poten-
tials) in TS suggests impaired cochlear function which 
may be caused by a neuropathic disturbance or cochlear 
ganglion defects.13,25 In fact, “Turner mice” have a loss 
of auditory brainstem response with increased age.40
It has been speculated that estrogens have a protec-
tive effect on hearing.45 Wang et al.46 reported that an 
HVWURJHQUHFHSWRUşNQRFNRXW%(5.2PRXVHGHYHORSVD
neural hypocellularity in the somatosensory cortex, and 
Meltser et al.47 described that the BERKO mice are more 
susceptible to hearing problems after acoustic problems. 
Coleman et al.48 reported an improvement of BAEP in 
RYDULHFWRPL]HGUDWVDIWHUHVWURJHQUHSODFHPHQW2VWEHUJ
et al.19 reported that the relative risk of developing sen-
sorineural hearing loss in Turner’s syndrome was higher 
if estrogen replacement started above 13 years or if the 
ZRPHQZHUHHVWURJHQGHÀFLHQWIRU!\HDUV
It is not known, however, if the hearing impairment 
DVVRFLDWHGZLWKHVWURJHQGHÀFLHQF\ LV GXH WRSRRUPLQ-
HUDOL]DWLRQRIWKHFRFKOHDUFDSVXOHRUGXHWRWKHODFNRI
stimulation of estrogen receptors, resulting in an abnor-
mal inner ear development.38 This estrogen protector ef-
IHFWRQKHDULQJFRXOGQRWEHFRQÀUPHGE\RWKHULQYHVWL-
gators studying TS patients.19,30
Clinical manifestations
Most commonly, the mid-frequency SNHL in TS begins in 
the second or third decade (late childhood and early adul-
thood), although it has been reported in children younger 
than 10 years.20 With aging, the SNHL develops into a high-
frequency hearing loss, resulting, at the age 40, in hearing 
comparable to that of non-TS women at the age of 60.32,41 
It is important, when evaluating TS patients, to rule out 
common causes of high-frequency hearing loss, such as: oto-
toxicity and exposure do loud sounds.
Mixed hearing loss
0L[HGKHDULQJORVV0+/LQ76LVFKDUDFWHUL]HGE\WKHDVVR-
ciation of middle ear disorders and SNHL. The MHL is diagno-
sed when the bone conduction thresholds are greater than 
15 dBHL and air conduction thresholds greater than 25 dB, 
with air-bone gap greater than or equal to 15, in, at least, 
one frequency.49 The TS literature is further confused by the 
inclusion of mixed hearing losses, not separated into con-
ductive and sensorineural components, and often without 
IXUWKHU LGHQWLÀFDWLRQ RI WKH FRQWULEXWLRQ RI FKURQLF RWLWLV
media to bone-conduction levels.20
Screening for hearing loss in turner syndrome
Because ear disease has a profound impact on the quality of 
life in TS patients,16 parents and patient (in adolescence) 
should be made aware of the high prevalence of ear pro-
blems at the diagnosis of TS.50 In addition, the audiologist 
should suspect of TS when evaluating a child with mid-fre-
quency SNHL or chronic otitis media specially if there is an 
association with short stature, delayed puberty or physical 
stigmata.25,50
The high incidence of recurrent acute otitis media in 
JLUOVZLWK76HPSKDVL]HVWKHLPSRUWDQFHRIUHJXODURWRORJLFDO
check-ups not only to substantiate the diagnosis of patients 
with TS, but also to monitor these patients for possible con-
ductive or sensorineural hearing loss.8
The following approach is suggested to screen for oto-
ORJLFDOGLVRUGHUVLQ76QHRQDWDOVFUHHQLQJZLWK%$(3ÀUVW
audiometry between 18-24 months followed by annual 
audiometric and otolaringological evaluation. Those with 
otological problems should be referred for a specialist 
follow-up.23,30,31
It is important to identify the initial hearing loss at fre-
TXHQFLHVDERYHN+]EHIRUHLWSURJUHVVWRIUHTXHQFLHVFULW-
LFDO IRU YHUEDO FRPPXQLFDWLRQ :KHQ KHDULQJ GHÀFLWV DUH
diagnosed by conventional methods, impairment of commu-
nication may have already occurred.31 Thus high frequency 
audiological testing should be requested for all TS older than 
3 years because it can diagnose hearing loss before it is evi-
dent at a routine audiometry.25,31 Since the average mid-fre-
TXHQF\ KHDULQJ ORVV LQ WKH+XOWFUDQW] HW DO47 study had a 
mean of 18.8 dB, a degree of hearing loss, not detected by 
the routine 20 dB pure-tone hearing screening, is important 
to obtain air and bone conduction thresholds for any child 
suspected of having TS.25
Impedance audiometry is indicated to check the condi-
tion of the middle ear (e.g., tympanic membrane continuity, 
PLGGOH HDU SUHVVXUH SUHVHQFH RI VWDSHGLDOPXVFOH UHÁH[
temporal bone computed tomography is indicated for  pa-
tients with a progressive middle ear disease and choleste-
atoma; BAEP should be requested when there is a need to 
investigate cochlear damage;30 and DPOAEs (Distortion Prod-
ucts Otoacoustic Emission) may be indicated to assess the 
function of the cochlear microphonics, checking if the outer 
hearing cells are functioning properly.
Conclusions
Otological disease and hearing loss are frequent in TS. 
The middle ear disturbances begin in early childhood, 
and the hearing loss in the first decade. Both can pro-
gress to auditory impairment and social disability (e.g., 
impaired speech or even intellectual development) if 
they are not diagnosed and treated precociously. The 
only successful intervention to reduce hearing loss in TS 
patients is assiduous and appropriate treatment of their 
auditory problems. Morphologic studies of the organ of 
Corti and the vestibulocochlear nerve in both fetal and 
adult TS are necessary to help out in clarifying the etio-
logy of the SNHL.
&RQÁLFWVRILQWHUHVW
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